Nasus Pharma Ltd. (NYSEAMERICAN:NSRX) Short Interest Down 39.6% in August

Nasus Pharma Ltd. (NYSEAMERICAN:NSRX) saw a large decrease in short interest in August. As of August 31st, there was short interest totaling 87,272 shares, a decrease of 39.6% from the August 15th total of 144,506 shares. Based on an average daily volume of 14,783 shares, the short-interest ratio is presently 5.9 days. Approximately 0.7% of the company’s shares are sold short.

Nasus Pharma Trading Down 1.7%

NSRX stock traded down $0.06 during mid-day trading on Wednesday, reaching $3.53. The company’s stock had a trading volume of 4,948 shares, compared to its average volume of 86,082. Nasus Pharma has a 12 month low of $1.98 and a 12 month high of $9.50. The business’s 50 day moving average price is $3.45 and its 200 day moving average price is $3.25.

Nasus Pharma (NYSEAMERICAN:NSRX) last posted its earnings results on Monday, August 17th. The company reported ($0.27) earnings per share (EPS) for the quarter. Research analysts forecast that Nasus Pharma will post -0.93 earnings per share for the current year.

Nasus Pharma Company Profile

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.